By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Overview
This guideline by the American College of Chest Physicians and the Canadian Thoracic Society provides a rigorous, evidence-based analysis of randomized controlled trial data regarding the prevention of COPD exacerbations.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: April 1, 2015
Contact: practice@apta.org
Content Type: CPG
Chronic Obstructive Pulmonary Disease (COPD)
Aged (65+), 80 and over (80+), Middle Aged (45-64), Adult (25-44)
Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marcinuik DD, Mularski RA, Omelas J, Road, JD, Stickland MK; American College of Chest Physicians; Canadian Thoracic Society
You Might Also Like...
CPG
The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2020, Version 2.68Oct 1, 2022
The COPDX Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2019 (Vers. 2.59)
CPG
VA/DoD Clinical Practice Guideline for the Management of Chronic Obstructive Pulmonary Disease (Revised), v. 3.0Apr 1, 2021
This guideline describes the critical decision points in the management of COPD and provides clear and comprehensive evidence based recommendations.
CPG
Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management [NG115]Jul 26, 2019
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (including emphysema and chronic bronchitis) in people aged